Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. van der Heide is active.

Publication


Featured researches published by S. van der Heide.


Clinical & Experimental Allergy | 2006

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo‐controlled trial

Ml Brouwer; Saa Wolt-Plompen; Anthony Dubois; S. van der Heide; Desiree Jansen; Ma Hoijer; Henk F. Kauffman; E. J. Duiverman

Background Studies have been performed suggesting that administration of probiotics may have therapeutic and/or preventive benefits in the development of sensitization and atopic disease, particularly in infants with atopic dermatitis (AD).


European Respiratory Journal | 1997

Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers

S. van der Heide; Hf Kauffman; A. E. J. Dubois; J. G. R. De Monchy

Recommendations for allergen avoidance or allergen reduction measures play an important part in the treatment of allergic asthmatic patients. The purpose of this study was to test recently developed air-cleaners with respect to their capacity to capture airborne allergen particles and to improve clinical parameters of asthmatic patients sensitized to aeroallergens. Forty five allergic asthmatic patients were studied in a double-blind procedure for 6 months. The patients were divided into three groups of 15 patients. In Group 1, the intervention consisted of the application of active air-cleaners in living-rooms and bedrooms. In Group 2, placebo air-cleaners were used in combination with allergen-impermeable mattress covers. In Group 3, the same intervention was performed as in Group 2 but with active air-cleaners. Allergen levels in mattress and floor dust were measured before, and 3 and 6 months after the interventions. After 6 months, the air-cleaners were dismantled and the filters were analysed for the amount of dust collected and allergen content. Immunological and lung function parameters were measured before, and 3 and 6 months after the interventions. Considerable amounts of airborne dust and allergenic particles were captured in the filters of the air-cleaners. Up to the 18.9 g of dust, 4,513 ng of house dust mite allergen, Der p 1, and 50,000 mU of cat allergen, Fel d 1, (in houses with cats) were collected by air-cleaners in living-rooms. Only in Group 3 (in which both active air-cleaners and mattress covers were used) was a small (less than 1 doubling dose) but statistically significant improvement of provocative concentration of histamine causing a 20% fall in forced expiratory volume in one second (PC20) observed (from 5.96 to 9.02 mg x mL(-1)). The amount of dust and house dust mite allergen collected in the filters was significantly correlated with an improvement of peak flow variation. In combination with other allergen avoidance measures, the examined air-cleaners can contribute to diminished allergen exposure and improvement of airway hyperresponsiveness in asthmatic patients.


Allergy | 2007

Placebo reactions in double‐blind, placebo‐controlled food challenges in children

B. J. Vlieg-Boerstra; S. van der Heide; C. M. A. Bijleveld; J. Kukler; E. J. Duiverman; Anthony Dubois

Background:  A cardinal feature of the double‐blind, placebo‐controlled food challenge (DBPCFC) is that placebo administration is included as a control. To date, the occurrence and diagnostic significance of placebo events have not extensively been documented.


Clinical & Experimental Allergy | 1999

Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids

S.G.M. Cloosterman; Tjard Schermer; I.D. Bijl-Hofland; S. van der Heide; Bert Brunekreef; F.J.J. van den Elshout; C.L.A. van Herwaarden; C.P. van Schayck

Exposure to house dust mite (HDM) allergens often results in worsening of asthma. Therefore, avoidance of exposure to HDM allergens is often proposed. Unfortunately, the most effective and feasible avoidance strategy is still not completely assessed. Consequently, we investigated the effects of a combined HDM avoidance strategy on HDM allergen concentrations and clinical condition of allergic, mild asthmatic, patients using no inhaled steroids.


Clinical & Experimental Allergy | 1997

Seasonal differences in airway hyperresponsiveness in asthmatic patients: relationship with allergen exposure and sensitization to house dust mites

S. van der Heide; J. G. R. De Monchy; K. de Vries; A. E. J. Dubois; Hf Kauffman

Background The degree of airway hyperresponsiveness in allergic asthmatic patients may be influenced by changes in environmental exposure to inhalant allergens.


Allergy | 2012

Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.

J.J. van Doormaal; E. van der Veer; P. C. van Voorst Vader; Philippus Kluin; André B. Mulder; S. van der Heide; Suzanne Arends; Johanna Kluin-Nelemans; J. N. G. Oude Elberink; J. G. R. De Monchy

Risk indicators of indolent systemic mastocytosis (ISM) in adults with clinical suspicion of ISM without accompanying skin lesions [urticaria pigmentosa (UP)] are lacking. This study aimed at creating a decision tree using clinical characteristics, serum tryptase, and the urinary histamine metabolites methylimidazole acetic acid (MIMA) and methylhistamine (MH) to select patients for bone marrow investigations to diagnose ISM.


Allergy | 2011

Validation of novel recipes for double‐blind, placebo‐controlled food challenges in children and adults

B. J. Vlieg-Boerstra; I. Herpertz; L. Pasker; S. van der Heide; J. Kukler; C. Jansink; W. Vaessen; B.J. Beusekamp; Anthony Dubois

To cite this article: Vlieg‐Boerstra BJ, Herpertz I, Pasker L, van der Heide S, Kukler J, Jansink C, Vaessen W, Beusekamp BJ, Dubois AEJ. Validation of novel recipes for double‐blind, placebo‐controlled food challenges in children and adults. Allergy 2011; 66: 948–954.


Clinical & Experimental Allergy | 2009

Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings

J. N. G. Oude Elberink; S. van der Heide; Gordon H. Guyatt; Anthony Dubois

Background In many European centers insect venom allergic patients with a reaction confined to the skin are only offered an epinephrine auto‐injector and not venom immunotherapy (VIT). Previously we showed that VIT improves health‐related quality of life (HRQL) of yellow jacket allergic patients with more than dermal reactions.


Allergy | 2011

Identification of low allergenic apple cultivars using skin prick tests and oral food challenges

B. J. Vlieg-Boerstra; W.E. van de Weg; S. van der Heide; Marjan Kerkhof; Paul Arens; G. Heijerman-Peppelman; Anthony Dubois

To cite this article: Vlieg‐Boerstra BJ, van de Weg WE, van der Heide S, Kerkhof M, Arens P, Heijerman‐Peppelman G, Dubois AEJ. Identification of low allergenic apple cultivars using skin prick tests and oral food challenges. Allergy 2011; 66: 491–498.


Contact Dermatitis | 2006

Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine)

A. J. Hogen Esch; S. van der Heide; W. van den Brink; J.M. van Ree; Derk P. Bruynzeel; Pieter Jan Coenraads

After the start of heroin (diacetylmorphine)‐assisted treatment to a selected group of chronic treatment‐resistant heroin‐dependent patients in the Netherlands, we reported about work‐related eczema and positive patch tests to heroin in some nurses and nasal and respiratory complaints. To investigate the prevalence of heroin contact allergy, we started a questionnaire‐based study with follow‐up by allergological examinations. Of 120 questionnaires sent, 101 (84%) was returned: 67 from nurses and 34 from other employees. Of 101 workers, 38 (38%) had reported work‐related complaints: 33 of 67 (49%) nurses and 5 of 34 (15%) other employees. Patch tests to heroin were performed in 24 nurses and were positive in 8 (33%). All the 8 had eyelid or facial eczema and, in 6, accompanied by mucosal or respiratory complaints. The prevalence of heroin contact allergy in this study was 8% (8/101) among all employees and 12% (8/67) among nurses. Respiratory and mucosal complaints could not be ascribed to a contact allergy, and in these cases, serum was analysed for specific immunoglobulin E to heroin. A type 1 allergy to heroin could not be shown. These complaints are possibly due to the histamine‐liberating effect of heroin, to atopic constitution, to a combination of these factors or – less likely – to other non‐allergic factors.

Collaboration


Dive into the S. van der Heide's collaboration.

Top Co-Authors

Avatar

Anthony Dubois

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Kukler

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. G. R. De Monchy

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

C.M.A. Bijleveld

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

B. M. J. Flokstra-de Blok

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

J. N. G. Oude Elberink

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Marjan Kerkhof

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

B.J. Beusekamp

University Medical Center Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge